Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Bone mineral density and risk of breast cancer in postmenopausal women.

Qu X, Zhang X, Qin A, Liu G, Zhai Z, Hao Y, Li H, Zhu Z, Dai K.

Breast Cancer Res Treat. 2013 Feb;138(1):261-71. doi: 10.1007/s10549-013-2431-3. Epub 2013 Feb 5.

PMID:
23381744
2.

Bone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studies.

Qu X, Huang X, Jin F, Wang H, Hao Y, Tang T, Dai K.

Int J Cardiol. 2013 Jun 20;166(2):385-93. doi: 10.1016/j.ijcard.2011.10.114. Epub 2011 Nov 21. Review.

PMID:
22112679
3.

Meta-analysis of walking for preservation of bone mineral density in postmenopausal women.

Martyn-St James M, Carroll S.

Bone. 2008 Sep;43(3):521-31. doi: 10.1016/j.bone.2008.05.012. Epub 2008 May 26.

PMID:
18602880
4.

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326.

PMID:
16856092
5.

Bone mineral density and risk of postmenopausal breast cancer.

Grenier D, Cooke AL, Lix L, Metge C, Lu H, Leslie WD.

Breast Cancer Res Treat. 2011 Apr;126(3):679-86. doi: 10.1007/s10549-010-1138-y. Epub 2010 Sep 14.

PMID:
20838879
6.

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.

Jolly EE, Bjarnason NH, Neven P, Plouffe L Jr, Johnston CC Jr, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.

Menopause. 2003 Jul-Aug;10(4):337-44.

PMID:
12851517
7.

Bone mineral density and breast cancer risk in postmenopausal women.

Buist DS, LaCroix AZ, Barlow WE, White E, Weiss NS.

J Clin Epidemiol. 2001 Apr;54(4):417-22.

PMID:
11297892
8.

Independent predictors of all osteoporosis-related fractures among healthy Saudi postmenopausal women: the CEOR Study.

Rouzi AA, Al-Sibiani SA, Al-Senani NS, Radaddi RM, Ardawi MS.

Bone. 2012 Mar;50(3):713-22. doi: 10.1016/j.bone.2011.11.024. Epub 2011 Dec 8.

PMID:
22178778
9.

Bone mineral density and bone turnover in postmenopausal women treated for breast cancer.

Waltman NL, Ott CD, Twiss JJ, Gross GJ, Lindsey AM, Moore TE.

Cancer Nurs. 2008 May-Jun;31(3):182-90. doi: 10.1097/01.NCC.0000305722.75647.26.

PMID:
18453874
10.

Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors.

Cauley JA, Song J, Dowsett SA, Mershon JL, Cummings SR.

Breast Cancer Res Treat. 2007 Apr;102(2):181-8. Epub 2006 Sep 21.

PMID:
17028986
11.

Bone mineral density and the risk of breast cancer: the Rotterdam Study.

van der Klift M, de Laet CE, Coebergh JW, Hofman A, Pols HA; Rotterdam Study.

Bone. 2003 Mar;32(3):211-6.

PMID:
12667548
12.

Axial BMD, change in BMD and bone turnover do not predict breast cancer incidence in early postmenopausal women.

Stewart A, Kumar V, Torgerson DJ, Fraser WD, Gilbert FJ, Reid DM.

Osteoporos Int. 2005 Dec;16(12):1627-32. Epub 2005 Mar 22.

PMID:
15782281
13.

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

PMID:
15840882
14.

Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative.

Chen Z, Arendell L, Aickin M, Cauley J, Lewis CE, Chlebowski R; Women's Health Initiative Program, National Heart, Lung and Blood Institute, US Department of Health and Human Services.

Cancer. 2008 Sep 1;113(5):907-15. doi: 10.1002/cncr.23674.

15.

Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.

Trémollieres FA, Pouillès JM, Drewniak N, Laparra J, Ribot CA, Dargent-Molina P.

J Bone Miner Res. 2010 May;25(5):1002-9. doi: 10.1002/jbmr.12.

16.

Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients.

Lee SA, Hwang SH, Ahn SG, Lee HM, Jeong J, Lee HD.

Breast Cancer Res Treat. 2011 Dec;130(3):863-70. doi: 10.1007/s10549-011-1728-3. Epub 2011 Aug 23.

PMID:
21861101
17.
18.

Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years.

Love RR, Barden HS, Mazess RB, Epstein S, Chappell RJ.

Arch Intern Med. 1994 Nov 28;154(22):2585-8.

PMID:
7979855
19.

Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.

Sornay-Rendu E, Munoz F, Duboeuf F, Delmas PD; OFELY Study.

J Bone Miner Res. 2004 Dec;19(12):1994-9. Epub 2004 Sep 13.

20.

Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study.

Nguyen TV, Center JR, Eisman JA.

Maturitas. 2000 Jul 31;36(1):27-34.

PMID:
10989239

Supplemental Content

Support Center